Summary of Amendments Submitted to the Rules Committee for H.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act

Summaries Derived from Information Provided by Sponsors

Listed in Alphabetical Order

June 19, 2018 4:54 PM

Click on sponsor for amendment text

Barton (TX), Meadows (NC), Kuster, Ann (NH)


Directs the Commissioner of Food and Drugs to develop high-quality, evidence-based opioid analgesic prescribing guidelines for the indication-specific treatment of acute pain. In developing such guidelines,it would require the Commissioner of Food and Drugs to gather input through a public workshop and comment period, and to provide a report to Congress on how such guidelines will be used to protect the public health.

Curtis, John (UT)


Requires a report from HHS on opioid prescribing practices and opioid misuse during pregnancy, and evaluating non-opiate pain management practices during pregnancy.

Davis, Danny K. (IL), Gallagher (WI)


REVISED Advances opioid abuse prevention by addressing the social and emotional harm caused by childhood traumatic experiences that often underlie opioid use; specifically, the amendment identifies and disseminates best practices within Federal Grant Programs by establishing a multi-agency federal Task Force, led by the Assistant Secretary for Mental Health, to recommend a set of best practices for identifying, referring, supporting, and fostering safe, nurturing environments for children and families that have experienced trauma.

Dunn (FL), Marshall (KS), Harris (MD), Roe (TN)


Strikes language expanding the classes of health care workers who are authorized to dispense narcotics for narcotic treatment.

Esty (CT), MacArthur (NJ), Larson, John (CT), Kuster, Ann (NH)


Authorizes a grant through SAMSHA to allow government and nonprofit agencies to facilitate addiction prevention programs that educate young people and those who work with them, such as coaches and teachers, on the risks associated with opioids and other prescription medication to prevent misuse and youth addiction.

Esty (CT), MacArthur (NJ), Kuster, Ann (NH)


Authorizes a grant to state, local, and tribal governments to support the work of forensic science labs and medical examiner offices in addressing the opioid crisis and to investigate the distribution, sale, and use of heroin, fentanyl, and associated synthetic drugs.

Green, Gene (TX)


Amends title XIX (Medicaid) of the Social Security Act to provide the enhanced federal medical assistance percentage (FMAP) to every state that expands Medicaid coverage for individuals who are newly eligible under the Patient Protection and Affordable Care Act, regardless of when such expansion takes place.

Keating (MA), Rothfus (PA)


Directs HHS to issue guidelines for prescribing naloxone in situations involving any type of prescription or illicit opioid use.

Lujan Grisham (NM)


Allows advanced practice pharmacists to proscribe buprenorphine in order to help combat the opioid epidemic.

Maloney, Sean (NY)


LATE Requires the Department of Health and Human Services to establish a grant program for public libraries to provide training for employees to use naloxone rescue kits.

Marino (PA), Blackburn (TN), Bilirakis (FL)


LATE Modifies the Drug Enforcement Administration's (DEA) standard of review for Immediate Suspension Orders (ISO) from "substantial likelihood" to "reasonably foreseeable risk," revises "immediate threat" to "imminent threat," adds "diversion" to the standard of review, and eliminates the Corrective Action Plan (CAP).

Meadows (NC)


Requires the Government Accountability Office to conduct a comprehensive report on health care policy changes that may have contributed to the increase in opioid overdoses and deaths.

Meng (NY)


Permits any controlled substance to be delivered to drug disposal locations registered with the Drug Enforcement Agency.

Moore, Gwen (WI)


LATE Provides guidance and training on comprehensive autopsies and first responders in the event of an event death to determine if drug addiction of a caregiver contributed to death. Requires an HHS study on the role of opioid addiction of caregivers on infant deaths.

Peterson (MN), Fitzpatrick (PA)


Repeals fully the "Ensuring Patient Access and Effective Drug Enforcement Act of 2015" and restores DEA's authority to carry out needed enforcement actions to combat the opioid epidemic.

Plaskett, (VI)


REVISED Excludes Medicaid payments made available under the bill from the statutory cap on Medicaid payments and the rate of matching funds made to Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa.

Schakowsky (IL)


Expands the definition of “covered recipient” in reporting requirements for opioid manufacturers.

Turner (OH), Kuster, Ann (NH)


Makes inmates housed in public institutions eligible for substance abuse treatment services, through Medicaid, at the discretion of the State. Additionally, eliminates Substance Abuse and Mental Health Services Administration's (SAMHSA) policy that prevents SAMHSA funding from going toward substance abuse treatment services for individuals who are incarcerated.

Turner (OH), Kuster, Ann (NH)


Eliminates Substance Abuse and Mental Health Services Administration's (SAMHSA) policy that prevents SAMHSA funding from going toward substance abuse treatment services for individuals who are incarcerated.

Walden (OR), Pallone (NJ), Brady, Kevin (TX), Neal (MA)


MANAGER’S AMENDMENT LATE Calls for Medicaid, Medicare, and public health reforms to help combat the opioid crisis. The policies contained in H.R. 6 were advanced through regular order by the House Energy and Commerce and Ways and Means Committees.

Walden (OR)


LATE Makes a technical correction to ensure that the matter incorporated into H.R. 6 is identical to the legislation previously adopted by the House.

Waters (CA)


LATE Directs the Secretary of Health and Human Services (HHS) to conduct a survey of organizations that provide substance abuse treatment services. Under the amendment, HHS is required to develop, and submit to Congress, a plan to direct appropriate resources to address inadequacies in services or funding for specific types of drug addictions identified through the survey.

Watson Coleman (NJ)


Provides congressional apology for its role regarding the War on Drugs.